Publikation

Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs.

Wissenschaftlicher Artikel/Review - 15.10.2012

Bereiche
PubMed
DOI
Kontakt

Zitation
Emanuel R, Dueck A, Geyer H, Kiladjian J, Slot S, Zweegman S, te Boekhorst P, Commandeur S, Schouten H, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl H, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto J, Ranta D, Roy L, Cahn J, Harrison C, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson P, Barbui T, Barosi G, Vannucchi A, Passamonti F, Andreasson B, Ferrari M, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa R. Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol 2012; 30:4098-103.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
J Clin Oncol 2012; 30
Veröffentlichungsdatum
15.10.2012
eISSN (Online)
1527-7755
Seiten
4098-103
Kurzbeschreibung/Zielsetzung

Myeloproliferative neoplasm (MPN) symptoms are troublesome to patients, and alleviation of this burden represents a paramount treatment objective in the development of MPN-directed therapies. We aimed to assess the utility of an abbreviated symptom score for the most pertinent and representative MPN symptoms for subsequent serial use in assessing response to therapy.